873055-56-2

Basic information

• Product Name: Carbonic acid 2,4-di-tert-butyl-6-Nitro-phenyl ester Methyl ester
• Synonyms: Carbonic acid 2,4-di-tert-butyl-6-Nitro-phenyl ester Methyl ester
• CAS NO: 873055-56-2
• Molecular Formula: C₁₆H₂₃NO₅
• Molecular Weight: 309.35752
• EINECS: -0
• Mol File: 873055-56-2.mol
• Article Data: 21

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbonic acid 2,4-di-tert-butyl-6-Nitro-phenyl ester Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbonic acid 2,4-di-tert-butyl-6-Nitro-phenyl ester Methyl ester(873055-56-2)
• EPA Substance Registry System: Carbonic acid 2,4-di-tert-butyl-6-Nitro-phenyl ester Methyl ester(873055-56-2)

Safety Data

• Hazardous Substances Data: 873055-56-2(Hazardous Substances Data)

Upstream product

• 873055-54-0 carbonic acid 2,4-di-tert-butyl-phenyl ester methyl ester 
• 96-76-4 2,4-di-tert-Butylphenol 

Downstream Products

• 873055-57-3 2,4-di-tert-butyl-5-nitro-phenol 
• 20039-94-5 2,4-di-tert-butyl-6-nitrophenol 

Relevant articles and documents

METHODS OF TREATMENT FOR CYSTIC FIBROSIS

This application describes methods of treating cystic fibrosis or a CFTR mediated disease comprising administering Compound I or a pharmaceutically acceptable salt thereof. (I) The application also describes pharmaceutical compositions comprising Compound I or a pharmaceutically acceptable salt thereof and optionally comprising one or more additional CFTR modulating agents.

PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

The disclosure provides processes for synthesizing compounds for use as CFTR modulators.

METHODS OF TREATMENT FOR CYSTIC FIBROSIS

Compound I of the formula (I) and/or pharmaceutically acceptable salt(s) of Compound I comprised in a pharmaceutical composition and methods of using the same to treat cystic fibrosis.